Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil with propofol for spontaneous-ventilation triple endoscopy
2008-007758-36Phase 4Active
- Sponsor
- CHU de Besançon
- Start
- Mar 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Pharyngolaryngeal neoplasm comparing Remifentanil + propofol with Placebo + propofol (2 arms). Primary endpoints: Improvement in endoscopic conditions, Safety and 1 more. Started Mar 2009; status: active.
02
Drugs
remifentanilpropofol
03
Conditions
Pharyngolaryngeal neoplasm
Beyond the preview
Go deeper on 2008-007758-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007758-36.